25 facts to defend trans rights

The AAP (67,000 pediatricians), the AMA (250,000+ physicians), the Endocrine Society, the American Psychological Association, the American Psychiatric Association, and 25+ others have issued formal position statements in support. No major medical organization opposes the non-surgical components of gender-affirming care: psychological support, social transition, puberty blockers, or hormone therapy.

GnRH agonists have been prescribed to children with precocious (early) puberty for over 30 years. Same drug, same dose. They weren't controversial until they were used for trans kids.

No reputable clinic skips to hormones. The pathway is: assessment, then social transition, then puberty blockers (if appropriate), then hormones, then surgery (adults only, in most cases). The staged process typically takes years.

Tordoff et al. (2022), published in JAMA Network Open, followed trans youth over 12 months. Delays in prescribing resulted in 2–3x increases in depression and suicidal thoughts.

The Cornell "What We Know" project is the most comprehensive literature summary available. Not one study out of 55 found that transition made people worse off.

Puberty blockers and hormones were associated with improved mental health, better body image, and higher psychosocial functioning, with low regret. (Dopp et al., 2025)

Chen et al. (2023) tracked 315 trans and nonbinary youth. This is one of the most rigorous studies in the field, published in one of the most prestigious medical journals in the world.

Ryan et al. (2010, 2016) established this through the Family Acceptance Project. The effect size is enormous — nothing else in the research comes close as a protective factor.

Glenn et al. (2024) measured the association on a day-to-day basis. The connection between how parents respond and how their kids feel is immediate and direct.

Those children were never “trans” by any modern clinical definition. The studies also counted kids who dropped out and never came back as having “desisted.” Newhook et al. (2018) identified 12 specific methodological problems.

Olson et al. (2022) followed 317 socially transitioned children. 94% maintained a binary trans identity, 3.5% identified as nonbinary, 2.5% as cisgender.

Gülgöz et al. (2019), published in the Proceedings of the National Academy of Sciences, compared 317 trans children with cisgender siblings and controls. No difference in identity strength or consistency.

Bustos et al. (2021) meta-analysis. For comparison, regret rates for knee replacement and bariatric surgery are both around 20%.

Wiepjes et al. (2022). The evaluation process works — the kids who weren’t sure didn’t start in the first place.

Turban et al. (2021) found the most common reasons for detransition were family rejection, workplace discrimination, and financial barriers. The dominant narrative about detransition has it backwards.

JAMA Network Open (2024). This is not a matter of debate — it’s what the national data shows.

The surgical panic is focused on the 3%, not the 97%. Breast reduction in minors has been routine and uncontroversial for decades — until trans kids were involved.

JAMA Network Open (2024). It is effectively nonexistent. Politicians who describe children “getting sex changes” are describing something vanishingly rare.

Sweden, Finland, Norway, and Denmark tightened clinical guidelines within their publicly funded healthcare systems. US states passed criminal bans that remove the decision entirely from families and doctors. These are not the same thing. PolitiFact, AP News, and the BMJ have all documented this misrepresentation.

The same Sweden that US politicians cite as proof that “even liberal Europe is pulling back” expanded gender recognition access the following year.

Littman’s 2018 study surveyed parents recruited from anti-trans forums — never the children themselves. The journal issued a correction. Sixty-one medical organizations rejected it. Even the Cass Review rejected the social contagion explanation.

Nath et al. (2024), published in Nature Human Behaviour, used a natural-experiment design that supports causal inference — not just correlation. The 72% figure is for 13–17-year-olds after two years of a law being in effect.

This happened in 2025. The “we need more evidence” argument has an expiration date — and for many legislators, no amount of evidence will be enough.

Noone et al. (2025), published in BMC, found the review applied unusually strict evidence standards to gender-affirming care — stricter than those applied to virtually any other area of pediatric medicine. The Yale Law School critique (McNamara et al. 2024) documented cases where the review’s recommendations didn’t follow from its own data.

Sweden, Finland, Norway, and Denmark tightened clinical guidelines within their publicly funded healthcare systems. US states passed criminal bans that remove the decision entirely from families and doctors. These are not the same thing.

The same Sweden that US politicians cite as proof that “even liberal Europe is pulling back” expanded gender recognition access the following year.

Littman’s 2018 study surveyed parents recruited from anti-trans forums — never the children themselves. The journal issued a correction. Sixty-one medical organizations rejected it. Even the Cass Review rejected the social contagion explanation.

Nath et al. (2024), published in Nature Human Behaviour, used a natural-experiment design that supports causal inference — not just correlation. The 72% figure is for 13–17-year-olds after two years of a law being in effect.

This happened in 2025. The “we need more evidence” argument has an expiration date — and for many legislators, no amount of evidence will be enough.

Noone et al. (2025), published in BMC, found the review applied unusually strict evidence standards to gender-affirming care — stricter than those applied to virtually any other area of pediatric medicine. The Yale Law School critique (McNamara et al. 2024) documented cases where the review’s recommendations didn’t follow from its own data.

The American Psychiatric Association’s position statement: “Lack of gender-affirming interventions is not a neutral decision and may worsen dysphoria.” Doing nothing has consequences. The question isn’t whether to intervene — it’s whether to intervene with evidence-based medicine or with legislation.